CDMO

Innovating and Collaborating to Support Biopharma Beyond the Typical CDMO

Janet Hoogstraate, Ph.D.

NorthX Biologics

Gene Editing

MegaBulb DNA: a Non-Viral ssDNA Breakthrough Revolutionizing Gene Editing

Tom Adie, Ph.D.; Elena Stoyanova, Ph.D.

Touchlight

dbDNA

Revolutionizing the Genetic Medicine Landscape with Enzymatic DNA

Jill Makin

Touchlight

AAV

Overcoming Variability and Scaling Challenges in AAV Manufacturing

Rafal Garus

Viralgen Vector Core

Synthetic DNA

Transforming the Economics of AAV Manufacture While Optimizing Quality with dbDNA

Tom Merritt, Ph.D.

Touchlight

Cell and Gene Therapy Regulatory

Navigating Regulatory Complexity for Cell and Gene Therapies

Natasha Rivas

Viral Vectors

A Viral Vector CDMO Vision that Resonates

Drew Brennan; Chris Berger; Elie Hanania, Ph.D.; Dave Ingamells; Rami Barghout, PE

Avid Bioservices

Plasmid Manufacturing

Optimizing Plasmid Production to Meet Growing Demand

Cynthia A. Challener, Ph.D.; Danielle Alvarez

Pharma's Almanac

Viral Vector Manufacturing

Considerations in Viral Vector Analytical Development to Enable Smooth Transfer to Quality Control

Chris Berger; Kilian Witzel

Avid Bioservices

AAV Capsid Engineering

Expanding Patient Access to Gene Therapies through AAV Capsid Engineering

Damien Marsic, Ph.D.

Porton Advanced Solutions

Viral Vector Manufacturing

Optimizing Transient Transfection for Viral Vector Production

Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.

Pharma's Almanac

Viral Vectors

Risk-Based Optimization of Viral Vector Processes Adds Real Value

Elie Hanania, Ph.D.; Tatiana Mello, M.S.

Avid Bioservices

Cell and Gene Therapy

State of the Cell and Gene Therapy Market

James Grote

Nice Insight

Column: M&A

Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.

Nigel Walker

Nice Insight

Cell and Gene Therapy Analytics

Accelerating the Development of High-Quality Cell and Gene Therapies with Comprehensive, In-house Analytical Support

Hui Chen, Ph.D.

Porton Advanced Solutions

Viral Vector Manufacturing

Approaching Viral Vector Manufacturing With an Emphasis on Quality and Design

Chris Berger; Atef Khezri

Avid Bioservices